3Analytics is building the quiet machinery behind safer drugs and devices - software that reads the literature, watches for warning signals and helps regulated teams act before a data problem becomes a patient problem.
Caroline Shleifer is the founder and CEO of RegASK, a Singapore-based regtech company that pairs an AI engine built for regulatory content with a global network of 1,800+ subject matter experts. A pharmacist and scientist by training with a PharmD-PhD in medical physics from the University of Paris V, she spent years leading regulatory and scientific affairs across Asia Pacific at SPRIM before founding RegASK in 2018 to bring regulatory work into the AI era.
RegASK is a Singapore-based regtech company building an agentic AI regulatory intelligence platform for life sciences and consumer products teams. It monitors regulatory change across 160+ markets, pairs autonomous AI agents with a global community of 1,800+ regulatory experts to validate insights, and automates the workflows that turn regulatory updates into compliant action. Founded in 2018 by Caroline Shleifer, the company raised a $10M Series A in 2022 and in 2025 became the first vertical regulatory intelligence platform certified to ISO/IEC 42001 for AI management.
LegitScript is a Portland, Oregon-based internet and payments compliance company that helps banks, payment providers, and the world's largest platforms tell legitimate merchants and products from dangerous or illegal ones. Founded in 2007 to fight rogue online pharmacies, it now certifies businesses in high-risk sectors and monitors merchants, ad platforms, marketplaces, and social media across more than 60 high-risk areas, blending AI, human analysts, and a large product-classification database.
BreachRx is a San Francisco-based SaaS company that pioneered Cybersecurity Incident Response Management (CIRM) - treating a breach as an enterprise-wide business crisis rather than a purely technical problem. Its Rex Platform gives security, legal, communications, and executive teams a single secure workspace to coordinate response, automatically track regulatory reporting obligations, and preserve a defensible audit trail. Founded in 2017 by Andy Lunsford and Matt Hartley, the company raised a $15M Series A in 2025 and serves 100+ customers including Coinbase, American Express, and Commvault.
AppliedXL is a New York-based event-detection company that builds machine-learning systems - it calls them editorial algorithms - to spot early signals in clinical trials, biotech, and financial data before they become news. Founded in 2020 by former Wall Street Journal computational journalists Francesco Marconi and Erin Riglin out of the Newlab Venture Studio, the company mines public databases like ClinicalTrials.gov to flag trial delays, enrollment shortfalls, and irregular status changes across more than 100 risk categories, feeding real-time intelligence to life-sciences executives and investors. Its work powers STAT Trials Pulse and appears on the Bloomberg Terminal.
Clearpol is a San Francisco healthtech company that builds AI tools for post-acute and long-term care providers. Its platform reads a facility's clinical data and regulatory environment, then automates the paperwork nobody likes: drafting CMS Form 2567 Plans of Correction, flagging resident risk before it escalates, and answering questions about federal and state nursing-home regulations. Positioned as a compliance 'co-pilot' for skilled nursing facilities, Clearpol says it is trusted by 900+ long-term care facilities and has written thousands of Plans of Correction.
Daptic (formerly DiploAI) is a New York-based startup building AI-powered regulatory intelligence software for global manufacturers. Its platform monitors more than 10,000 regulatory sources across 200+ jurisdictions, flags relevant changes within 24 hours of publication, and turns them into product-specific compliance requirements - cutting the manual research that eats into engineering and compliance teams. Founded in 2023 by MIT alumni Baptiste Bouvier and Hannah Collins, the company got its start helping electric-vehicle and automotive makers keep pace with the roughly 1,000 regulatory updates issued worldwide each day, and has since broadened to manufacturers of all kinds.
RegDesk is an AI-powered regulatory information management platform for medical device, IVD, and pharma companies. It gives regulatory teams 24/7 access to up-to-date requirements across 120+ markets, automates submission-ready applications (GSPR checklists, Essential Principles, Declaration of Conformity), tracks changing regulations with daily alerts, and coordinates distributors - compressing submission work that once took three to six months into roughly a week.
Baptiste Bouvier is the founder and CEO of Daptic (formerly DiploAI), a New York-based AI startup building regulatory intelligence infrastructure for global manufacturers. The platform monitors more than 10,000 regulatory sources worldwide, flags changes within 24 hours, and helps engineering, product, and compliance teams act on obligations early. Raised between Tokyo, Sydney, London, and Boston by entrepreneur parents, Baptiste studied computer science and political science at MIT and public policy at Oxford, taught negotiation, founded MIT's first entrepreneurship club, and worked at McKinsey before turning regulatory bottlenecks into a company.
Priya Paul (Bhutani) is the founder and CEO of RegDesk, an AI-powered regulatory intelligence and management platform for medical device and pharmaceutical companies. A biomedical engineer turned regulatory strategist, she spent years watching life-changing devices stall in regulatory limbo - up to 80% of applications get rejected for reasons unrelated to safety - and built RegDesk in 2014 to compress submissions that once took months into days. She leads the company's product vision and global growth, and RegDesk is a certified Minority Business Enterprise.